Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Oscar Health ( (OSCR) ) has shared an announcement.
On September 16, 2025, Oscar Health announced the pricing of its upsized $355 million offering of 2.25% convertible senior subordinated notes due 2030, aimed at scaling long-term growth and adoption in the individual market. The proceeds from this offering will support general corporate purposes, including strategic AI initiatives and potential extension of premium tax credits, while also managing share dilution through capped call transactions.
The most recent analyst rating on (OSCR) stock is a Sell with a $11.00 price target. To see the full list of analyst forecasts on Oscar Health stock, see the OSCR Stock Forecast page.
Spark’s Take on OSCR Stock
According to Spark, TipRanks’ AI Analyst, OSCR is a Outperform.
Oscar Health’s strong financial performance and positive technical indicators are the primary drivers of its stock score. However, the negative P/E ratio and operational challenges highlighted in the earnings call weigh down the overall score. The company’s strategic initiatives and future profitability goals provide a cautiously optimistic outlook.
To see Spark’s full report on OSCR stock, click here.
More about Oscar Health
Oscar Health, Inc. operates in the health insurance industry, focusing on providing innovative health insurance solutions. The company is known for its use of technology and data-driven approaches to enhance consumer healthcare experiences, with a market focus on individual and employer health insurance plans.
Average Trading Volume: 27,358,145
Technical Sentiment Signal: Strong Buy
Current Market Cap: $4.84B
For an in-depth examination of OSCR stock, go to TipRanks’ Overview page.